530057 Stock Overview
Vivanza Biosciences Limited trades in pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Vivanza Biosciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹8.55 |
| 52 Week High | ₹16.97 |
| 52 Week Low | ₹5.70 |
| Beta | 0.89 |
| 1 Month Change | 29.74% |
| 3 Month Change | -1.72% |
| 1 Year Change | n/a |
| 3 Year Change | -22.87% |
| 5 Year Change | 348.82% |
| Change since IPO | 79.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530057 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -3.5% | -1.8% | -2.1% |
| 1Y | n/a | 65.0% | 45.3% |
Return vs Industry: Insufficient data to determine how 530057 performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how 530057 performed against the Indian Market.
Price Volatility
| 530057 volatility | |
|---|---|
| 530057 Average Weekly Movement | 8.6% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 530057's share price has been volatile over the past 3 months.
Volatility Over Time: 530057's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 5 | Jayendra Mehta | www.vivanzabiosciences.com |
Vivanza Biosciences Limited trades in pharmaceutical products in India. It also offers gloves and other surgical related products. Vivanza Biosciences Limited was incorporated in 1982 and is based in Ahmedabad, India.
Vivanza Biosciences Limited Fundamentals Summary
| 530057 fundamental statistics | |
|---|---|
| Market cap | ₹330.80m |
| Earnings (TTM) | ₹8.58m |
| Revenue (TTM) | ₹317.31m |
39.9x
P/E Ratio1.1x
P/S RatioIs 530057 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530057 income statement (TTM) | |
|---|---|
| Revenue | ₹317.31m |
| Cost of Revenue | ₹296.21m |
| Gross Profit | ₹21.10m |
| Other Expenses | ₹12.52m |
| Earnings | ₹8.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 6.65% |
| Net Profit Margin | 2.70% |
| Debt/Equity Ratio | 108.7% |
How did 530057 perform over the long term?
See historical performance and comparison